Which clinical feature best distinguishes stage IB cervical cancer from stage IIA cervical cancer according to FIGO 2009 staging?

Explanation

## FIGO 2009 Cervical Cancer Staging: IB vs IIA ### Key Distinction **Key Point:** Stage IIA is defined by vaginal involvement in the upper two-thirds WITHOUT parametrial invasion, whereas stage IB is confined to the cervix (regardless of size). ### Staging Comparison Table | Stage | Extent of Disease | Parametrial Involvement | Vaginal Involvement | | --- | --- | --- | --- | | **IB** | Confined to cervix | Absent | Absent | | **IIA** | Extends beyond cervix | **Absent** (key feature) | Upper 2/3 vagina | | **IIB** | Extends beyond cervix | **Present** (key feature) | Any vaginal involvement | | **IIIA** | Extends to lower 1/3 vagina | Any | Lower 1/3 vagina | ### Clinical Pearl **Clinical Pearl:** The critical discriminator between IIA and IB is **vaginal extension without parametrial involvement**. Once parametrial invasion occurs, the disease is automatically stage IIB, regardless of vaginal involvement. Size alone (>4 cm) does not change stage — it only affects substaging within stage I (IA1, IA2, IB1, IB2 in older FIGO 1995 system; now simplified to IB in FIGO 2009). ### High-Yield Points **High-Yield:** - Stage IB = cervix-confined (no size limit in FIGO 2009) - Stage IIA = vaginal involvement **without** parametrial spread - Stage IIB = parametrial involvement (with or without vaginal spread) - Parametrial invasion is the most important prognostic discriminator and changes management (chemotherapy dosing, brachytherapy planning) ### Why This Matters Parametrial status directly impacts prognosis and treatment intensity. Patients with parametrial involvement (IIB) have worse outcomes and require intensified concurrent chemoradiation, whereas IIA patients may be managed with external beam radiotherapy ± brachytherapy alone in selected cases. [cite:FIGO 2009 Cervical Cancer Staging Guidelines]